UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer

Nature reviews. Gastroenterology & hepatology, 2020-03, Vol.17 (3), p.153-168

2020

Volltextzugriff (PDF)

Targeting miR-21 for the Therapy of Pancreatic Cancer

Molecular therapy, 2013-05, Vol.21 (5), p.986-994

2013

Volltextzugriff (PDF)

Circulating Tumor Cell Clusters: United We Stand Divided We Fall

International journal of molecular sciences, 2020-04, Vol.21 (7), p.2653

2020

Volltextzugriff (PDF)

Salivary MicroRNA in Pancreatic Cancer Patients

PloS one, 2015-06, Vol.10 (6), p.e0130996-e0130996

2015

Volltextzugriff (PDF)

Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes

International journal of molecular sciences, 2017-06, Vol.18 (6), p.1231

2017

Volltextzugriff (PDF)

Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion

Oncogene, 2005-07, Vol.24 (31), p.4921-4933

2005

Volltextzugriff (PDF)

The Silencing of MicroRNA 148a Production by DNA Hypermethylation Is an Early Event in Pancreatic Carcinogenesis

Clinical chemistry (Baltimore, Md.), 2010-07, Vol.56 (7), p.1107-1118

2010

Volltextzugriff (PDF)

MicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions

Clinical chemistry (Baltimore, Md.), 2010-04, Vol.56 (4), p.603-612

2010

Volltextzugriff (PDF)

let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression

Human gene therapy, 2009-08, Vol.20 (8), p.831-844

2009

Volltextzugriff (PDF)

Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer

EBioMedicine, 2020-07, Vol.57, p.102858-102858, Article 102858

2020

Volltextzugriff (PDF)

Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities

European journal of cancer (1990), 2016-02, Vol.54, p.75-83

2016

Volltextzugriff (PDF)

Targeted oncolytic herpes simplex virus type 1 eradicates experimental pancreatic tumors

Human gene therapy, 2015-02, Vol.26 (2), p.104-113

2015

Volltextzugriff (PDF)

MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer

World journal of gastroenterology : WJG, 2014-08, Vol.20 (32), p.11199-11209

Gayral, Marion

2014

Volltextzugriff (PDF)

The rescue of miR-148a expression in pancreatic cancer: an inappropriate therapeutic tool

PloS one, 2013-01, Vol.8 (1), p.e55513

2013

Volltextzugriff (PDF)

Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation

Molecular biology of the cell, 2003-09, Vol.14 (9), p.3911-3928

2003

Volltextzugriff (PDF)

Inhibition of Growth and Metastatic Progression of Pancreatic Carcinoma in Hamster after Somatostatin Receptor Subtype 2 (sst2) Gene Expression and Administration of Cytotoxic Somatostatin Analog AN-238

Proceedings of the National Academy of Sciences - PNAS, 2000-08, Vol.97 (16), p.9180-9185

2000

Volltextzugriff (PDF)

Regulation of Neuronal Nitric-oxide Synthase Activity by Somatostatin Analogs following SST5 Somatostatin Receptor Activation

The Journal of biological chemistry, 2006-07, Vol.281 (28), p.19156-19171

2006

Volltextzugriff (PDF)

The Tyrosine Phosphatase SHP-1 Associates with the sst2 Somatostatin Receptor and Is an Essential Component of sst2-mediated Inhibitory Growth Signaling

The Journal of biological chemistry, 1997-09, Vol.272 (39), p.24448-24454

1997

Volltextzugriff (PDF)

Initial Characterization of Integrase-Defective Lentiviral Vectors for Pancreatic Cancer Gene Therapy

Human gene therapy, 2016-02, Vol.27 (2), p.184-192

2016

Volltextzugriff (PDF)

Antiproliferative Effect of Somatostatin and Analogs

Chemotherapy (Basel), 2001-01, Vol.47 (Suppl 2), p.30-39

2001

Volltextzugriff (PDF)

PNL2, a New Monoclonal Antibody Directed against a Fixative-Resistant Melanocyte Antigen

Modern pathology, 2003-05, Vol.16 (5), p.481-490

2003

Volltextzugriff (PDF)

The antitumoral activity of TLR7 ligands is corrupted by the microenvironment of pancreatic tumors

Molecular therapy, 2022-04, Vol.30 (4), p.1553-1563

2022

Volltextzugriff (PDF)

Characterization of the Antiproliferative Signal Mediated by the Somatostatin Receptor Subtype sst5

Proceedings of the National Academy of Sciences - PNAS, 1997-08, Vol.94 (17), p.9343-9348

1997

Volltextzugriff (PDF)

sst2 Somatostatin Receptor Mediates Negative Regulation of Insulin Receptor Signaling through the Tyrosine Phosphatase SHP-1

The Journal of biological chemistry, 1998-03, Vol.273 (12), p.7099-7106

1998

Volltextzugriff (PDF)

Signal transduction of somatostatin receptors negatively controlling cell proliferation

Journal of physiology, Paris, 2000-05, Vol.94 (3), p.205-210

2000

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Aktive Filter

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(54)

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer

Targeting miR-21 for the Therapy of Pancreatic Cancer

Circulating Tumor Cell Clusters: United We Stand Divided We Fall

Salivary MicroRNA in Pancreatic Cancer Patients

Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes

Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion

The Silencing of MicroRNA 148a Production by DNA Hypermethylation Is an Early Event in Pancreatic Carcinogenesis

MicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions

let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression

Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer

Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities

Targeted oncolytic herpes simplex virus type 1 eradicates experimental pancreatic tumors

MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer

The rescue of miR-148a expression in pancreatic cancer: an inappropriate therapeutic tool

Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation

Inhibition of Growth and Metastatic Progression of Pancreatic Carcinoma in Hamster after Somatostatin Receptor Subtype 2 (sst2) Gene Expression and Administration of Cytotoxic Somatostatin Analog AN-238

Regulation of Neuronal Nitric-oxide Synthase Activity by Somatostatin Analogs following SST5 Somatostatin Receptor Activation

The Tyrosine Phosphatase SHP-1 Associates with the sst2 Somatostatin Receptor and Is an Essential Component of sst2-mediated Inhibitory Growth Signaling

Initial Characterization of Integrase-Defective Lentiviral Vectors for Pancreatic Cancer Gene Therapy

Antiproliferative Effect of Somatostatin and Analogs

PNL2, a New Monoclonal Antibody Directed against a Fixative-Resistant Melanocyte Antigen

The antitumoral activity of TLR7 ligands is corrupted by the microenvironment of pancreatic tumors

Characterization of the Antiproliferative Signal Mediated by the Somatostatin Receptor Subtype sst5

sst2 Somatostatin Receptor Mediates Negative Regulation of Insulin Receptor Signaling through the Tyrosine Phosphatase SHP-1

Signal transduction of somatostatin receptors negatively controlling cell proliferation

Aktive Filter

Suchergebnisse filtern